Ipsen Posts Higher H1 Profit, Signs New Partnership With Day One For Tovorafenib
25/7 08:05
(RTTNews) - French biopharmaceutical company Ipsen (IPSEY) on Thursday posted higher profit and sales for the half year, and said it signed a new global partnership with Day One Biopharmaceuticals to commercialize tovorafenib outside the U.S....